AbCellera Biologics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Aug 24 | BuyUS$739,977 | Carl Hansen | Individual | 283,516 | US$2.61 | |
08 Nov 23 | BuyUS$137,400 | John Montalbano | Individual | 30,000 | US$4.64 |
Insider Trading Volume
Insider Buying: ABCL insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Hedge Funds | 27,525,640 | 9.34% |
Individual Insiders | 78,586,937 | 26.7% |
General Public | 89,136,910 | 30.3% |
Institutions | 99,416,045 | 33.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
56,927,884 | US$142.3m | 0.6% | no data | |||
27,525,640 | US$68.8m | 0% | 0.17% | |||
21,911,014 | US$54.8m | -5.47% | 0.02% | |||
10,632,460 | US$26.6m | 0% | 0.03% | |||
10,179,880 | US$25.4m | 0% | no data | |||
9,613,674 | US$24.0m | 0.87% | no data | |||
5,318,793 | US$13.3m | -36.3% | no data | |||
4,693,617 | US$11.7m | 4,500% | no data | |||
4,542,735 | US$11.4m | 0% | 0.01% | |||
4,490,520 | US$11.2m | 0% | 0.07% | |||
4,180,768 | US$10.5m | 0% | 0.14% | |||
4,180,547 | US$10.5m | 0% | 14.67% | |||
4,105,095 | US$10.3m | 0% | 0.12% | |||
3,803,477 | US$9.5m | -2.49% | no data | |||
2,656,016 | US$6.6m | -3.19% | 0.04% | |||
2,352,633 | US$5.9m | 31.4% | 1.76% | |||
2,061,356 | US$5.2m | 39.2% | 0.01% | |||
1,786,414 | US$4.5m | 0% | 0.44% | |||
1,764,800 | US$4.4m | 0.41% | 0.01% | |||
1,728,603 | US$4.3m | 16% | 0.01% | |||
1,570,535 | US$3.9m | 0% | 0.02% | |||
1,473,210 | US$3.7m | 92.6% | no data | |||
1,441,642 | US$3.6m | 0% | no data | |||
1,126,915 | US$2.8m | 0% | no data | |||
1,092,169 | US$2.7m | -45.9% | no data |